RxDoctor Payments Data

James Dangelo, DO

Family Medicine · Kansas City, MONPI 1093704314

Payments from drug & device makers

$7,896in general payments, 2019–2025

Across 524 payments — averaging $15.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$796
  • AstraZeneca$745
  • Novo Nordisk$626
  • Lilly USA, LLC$509
  • Amgen$377
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$7,885100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)93$1,334
Pfizer58$796
AstraZeneca45$745
Novo Nordisk43$626
Lilly USA, LLC30$509
Amgen26$377
GSK23$315
Antares Pharma, Inc.16$246
Sanofi-aventis U.S. LLC16$245
Boehringer Ingelheim13$211
Merck13$188
Amarin Pharma, Inc.10$143
Eisai Inc.8$120
Collegium Pharmaceutical, Inc.7$112
Biohaven Pharmaceuticals, Inc.7$109
Esperion Therapeutics, Inc.6$97
Jazz Pharmaceuticals Inc.6$97
Otsuka America Pharmaceutical, Inc.6$95
Takeda Pharmaceuticals U.S.A., Inc.8$95
Shire North American Group Inc6$92
Corium, LLC5$84
Johnson & Johnson5$81
Novartis6$75
Astellas Pharma US Inc5$68
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$68
Bayer4$67
Phathom Pharmaceuticals, Inc.4$66
Sumitomo Pharma America, Inc.4$60
Supernus Pharmaceuticals, Inc.3$58
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC3$50
Exact Sciences3$45
E.r. Squibb & Sons, L.L.C.3$44
Scilex Pharmaceuticals Inc.2$37
Lundbeck LLC2$36
Sanofi2$36
Ironshore Pharmaceuticals Inc.2$35
Sunovion Pharmaceuticals Inc.2$33
Radius Health, Inc.1$32
Bioventus LLC1$31
Axsome Therapeutics, Inc.2$30
Biohaven Pharmaceutical Holding Company Ltd.2$30
Daiichi Sankyo Inc.1$20
Alnylam Pharmaceuticals Inc.1$19
UCB, Inc.1$18
Abbott1$18
Tonix Medicines, Inc.1$16
Verity Pharmaceuticals Inc.1$15
IBSA Pharma Inc.1$15
Fidia Pharma USA Inc.1$15
Corcept Therapeutics1$14
Nabriva Therapeutics, PLC1$14
Sanofi Pasteur Inc.1$14
Exeltis, USA Inc.1$13
Idorsia Pharmaceuticals US Inc1$13
Teva Pharmaceuticals USA, Inc.1$13
Neos Therapeutics, LP1$12
Nalpropion Pharmaceuticals LLC1$12
Clarus Therapeutics Inc.1$12
Gilead1$12
Ironwood Pharmaceuticals, Inc1$11

How this compares

$7,896 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$82,852
Medicare patients
412
Services billed
1,118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide88$105,790
JardianceEmpagliflozin102$81,013
TrulicityDulaglutide55$77,565
JanuviaSitagliptin Phosphate45$46,376
MounjaroTirzepatide30$42,385
EliquisApixaban31$36,398
RybelsusSemaglutide20$19,251
MyrbetriqMirabegron27$15,552
XareltoRivaroxaban12$15,121
FarxigaDapagliflozin Propanediol21$12,959
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$11,191
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,910
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen320$6,460
Omeprazole324$4,601
Tamsulosin Hcl264$4,480

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$626$125,040108 claims
Lilly USA, LLCTrulicity, Mounjaro$509$119,95085 claims
Boehringer IngelheimJardiance$211$81,013102 claims
MerckJanuvia$188$46,37645 claims
PfizerEliquis$796$36,39831 claims
AstraZenecaFarxiga, Breztri Aerosphere$745$21,86935 claims
Astellas Pharma US IncMyrbetriq$68$15,55227 claims
Johnson & JohnsonXarelto$81$15,12112 claims
GSKTrelegy Ellipta$315$11,19117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →